Aptevo Therapeutics (APVO) Common Equity (2015 - 2026)
Aptevo Therapeutics (APVO) recorded Common Equity of $6.04 million in Q2 2026, down 7.4% from $6.52 million a year earlier and down 48.0% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Common Equity (2015 - 2026) Analysis & Trends
At the end of FY2025, Aptevo Therapeutics reported Common Equity of $17.38 million, up 265.5% from FY2024.
- Annual Common Equity has a five-year compound annual growth rate of 0.9% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $4.76 million in FY2024 (-61.1%), $12.22 million in FY2023 (-32.0%), $17.97 million in FY2022 and $1.22 million in FY2021 (-92.7%).
- The Q2 2026 figure is the lowest quarterly Common Equity since Q1 2025.
- On a year-over-year basis, Common Equity rose in three of the last six quarters, with growth averaging 77.8%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 293.5% in Q3 2025, against a decline of 92.7% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.61 million (Q1 2026), $17.38 million (Q4 2025) and $17.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Aptevo Therapeutics | 2.71 Mn | -64.29 Mn | - | 6.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.04 Mn |
| Mar 31, 2026 | 11.61 Mn |
| Dec 31, 2025 | 17.38 Mn |
| Sep 30, 2025 | 17.39 Mn |
| Jun 30, 2025 | 6.52 Mn |
| Mar 31, 2025 | -1.47 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Sep 30, 2024 | 4.42 Mn |
| Jun 30, 2024 | 4.46 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Dec 31, 2023 | 12.22 Mn |
| Sep 30, 2023 | 14.72 Mn |
| Jun 30, 2023 | 16.25 Mn |
| Mar 31, 2023 | 23.26 Mn |
| Dec 31, 2022 | 17.97 Mn |
| Sep 30, 2022 | 15.76 Mn |
| Jun 30, 2022 | 23.05 Mn |
| Mar 31, 2022 | -5.88 Mn |
| Dec 31, 2021 | 1.22 Mn |
| Sep 30, 2021 | 7.29 Mn |
API Access
Aptevo Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();